EA
EW icon

Emerald Acquisition’s Edwards Lifesciences EW Stock Holding History

Emerald Acquisition’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$65.7M Sell
1,634,310
-138,243
-8% -$5.21M 0.13% 182
2016
Q2 		$58.9M Buy
+1,772,553
New +$60.6M 0.1% 227

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Emerald Acquisition's EW Position: Q3 2016 in Review

Emerald Acquisition reduced its Edwards Lifesciences (EW) stake by 7.8% in Q3 2016, selling an estimated $5.21M and leaving 1,634,310 shares worth $65.7M. The position accounts for 0.13% of the portfolio, ranked #182.

Emerald Acquisition first reported a position in EW in Q2 2016 and has held it in 2 quarters since. 693 funds tracked by Wall St. Rank hold EW as of Q3 2016.

  • Emerald Acquisition held 1,634,310 shares of Edwards Lifesciences worth $65.7M as of Q3 2016.
  • Emerald Acquisition sold 138,243 Edwards Lifesciences shares in Q3 2016, an estimated $5.21M.
  • Edwards Lifesciences made up 0.13% of Emerald Acquisition's portfolio in Q3 2016, its #182 holding.
  • Emerald Acquisition first reported a position in Edwards Lifesciences in Q2 2016 and has held it in 2 quarters since.
  • 693 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.